相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time
G. Pasello et al.
ANNALS OF ONCOLOGY (2018)
MYC inhibition increases PD-L1 expression induced by IFN-γ in hepatocellular carcinoma cells
Jiahuan Zou et al.
MOLECULAR IMMUNOLOGY (2018)
Tumor-derived exosomes induce PD1(+) macrophage population in human gastric cancer that promotes disease progression
Furong Wang et al.
ONCOGENESIS (2018)
Regulatory mechanisms of PD-L1 expression in cancer cells
Yongyu Shi
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner
Carlos W. Wanderley et al.
CANCER RESEARCH (2018)
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Miguel F. Sanmamed et al.
CELL (2018)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
The role of PD-1 in regulation of macrophage apoptosis and its subversion by Leishmania donovani
Shalini Roy et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2017)
Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
Yoshihiro Komohara et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma: A Prognostic Marker and Therapeutic Target for Liver Cancer?
Antonio Solinas et al.
HEPATOLOGY (2016)
Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma: Relationship With Clinical and Pathological Features
Julien Calderaro et al.
HEPATOLOGY (2016)
Programmed death ligand 1 as an indicator of pre-existing adaptive immune responses in human hepatocellular carcinoma
Qian-Kun Xie et al.
ONCOIMMUNOLOGY (2016)
CD86+/CD206+, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis
Pingping Dong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future
Lieping Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Can macrophages within the microenvironment of locally invasive rectal cancers predict response to radiotherapy?
Shafaque Shaikh et al.
LANCET (2015)
Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases
Stefan Siebert et al.
PHARMACOLOGICAL REVIEWS (2015)
CD68+HLA-DR+ M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway
Hao Wang et al.
CANCER LETTERS (2014)
K63-linked polyubiquitination of IRF1: an essential step in the IL-1 signaling cascade
Tianxiao Wang et al.
Cellular & Molecular Immunology (2014)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines (vol 41, pg 14, 2014)
Peter J. Murray et al.
IMMUNITY (2014)
Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis
Ole Helm et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Conditioned media from macrophages of M1, but not M2 phenotype, inhibit the proliferation of the colon cancer cell lines HT-29 and CACO-2
Alexander Engstrom et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5
Kuzhuvelil B. Harikumar et al.
NATURE IMMUNOLOGY (2014)
M1 and M2: there is no good and bad-How macrophages promote malignancy-associated features in tumorigenesis
Ole Helm et al.
ONCOIMMUNOLOGY (2014)
NF-κB Plays a Key Role in Inducing CD274 Expression in Human Monocytes after Lipopolysaccharide Treatment
Gang Huang et al.
PLOS ONE (2013)
Cancer immunoediting by the innate immune system in the absence of adaptive immunity
Timothy O'Sullivan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Charles A. Dinarello et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer
Sofia Edin et al.
PLOS ONE (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
Ilia N. Buhtoiarov et al.
IMMUNOLOGY (2011)
A Critical Role for Macrophages in Promotion of Urethane-Induced Lung Carcinogenesis
Rinat Zaynagetdinov et al.
JOURNAL OF IMMUNOLOGY (2011)
Interleukin-1 (IL-1) Pathway
Axel Weber et al.
SCIENCE SIGNALING (2010)
Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival
C. M. Ohri et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
Dong-Ming Kuang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Induced B7-H1 expression on human renal tubular epithelial cells by the sublytic terminal complement complex C5b-9
Yongwen Chen et al.
MOLECULAR IMMUNOLOGY (2009)
Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-γ-induced upregulation of B7-H1 (CD274)
SJ Lee et al.
FEBS LETTERS (2006)
分享论文
